Related Experiment Video
Updated: Aug 25, 2026

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Direct Molecular Editing of Complex Molecules for Drug Discovery
Sidi Cheng1,2, Chunhua Ma3, Xiaoyu Chang4
1College of Chemistry, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China.
None:
Innovative synthetic methods that allow for the direct, efficient modification of complex lead compounds are essential for accelerating drug development. In particular, molecular editing enables the precise, late-stage diversification of privileged scaffolds, streamlining the drug optimization process. This review systematically evaluates the rapidly expanding repertoire of molecular editing, predominantly focusing on editing natural products and drug molecules. We classify these strategies into skeletal and peripheral editing, assembling recent representative cases that illustrate their utility in direct editing of complex molecules. Complementing these chemical approaches, biomimetic molecular editing (also called nature-inspired molecular editing) is briefly discussed. By highlighting strategies that enable the site-selective diversification of complex scaffolds, this review seeks to guide future efforts in the direct late-stage editing of natural products and drug molecules.
More Related Videos
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
Drug Discovery: Overview
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
RNA Editing
Homologous Recombination

